Gunderson Dettmer represented Enveda Biosciences on the deal.Enveda Biosciences, a drug discovery and development company, announced the additional $51 million equity financing, adding to the $68 million…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
